Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

From Recanalization to Failed Recovery: No Reflow, No Rescue, and No Regrow After Thrombectomy.

Created on 07 Aug 2026

Authors

Ariana Chacon, Dareen Hijazi, Ali Tfaily, Brian M Howard, Stephen Tomlinson, Jonathan A Grossberg, Ali M Alawieh

Published in

Translational stroke research. Volume 17. Issue 4. Aug 07, 2026. Epub Aug 07, 2026.

Abstract

Despite the remarkable technical success of endovascular thrombectomy (EVT) in achieving high recanalization rates for acute ischemic stroke due to large vessel occlusion (LVO), angiographic success does not consistently translate into functional recovery. Approximately 50% of successfully recanalized patients failed to achieve functional independence at 90 days, a phenomenon termed futile recanalization (FR). Futile recanalization highlights the biological limitations of macrovascular reperfusion alone. We propose a mechanistic framework for FR centered on the "3 R's" of stroke recovery: No-Reflow, No-Rescue, and No-Regrow. No-Reflow refers to microvascular failure despite proximal recanalization, driven by capillary obstruction, endothelial injury, pericyte constriction, and thromboinflammatory processes. No-Rescue describes secondary loss of initially salvageable neurons due to complement activation, neuroinflammation, oxidative stress, and blood-brain barrier dysfunction. No-Regrow reflects impaired neuroplasticity in the subacute and chronic phases, including failed neurogenesis, axonal degeneration, white matter injury, and disrupted network reorganization. This review examines the clinical, imaging, procedural, and molecular determinants of FR to better understand why successful reperfusion does not always result in neurological recovery. Understanding the multifactorial nature of FR is essential to improving EVT outcomes. Future strategies should target microvascular injury and inflammation, refine patient selection criteria, and explore adjunctive therapies aimed at restoring downstream perfusion and mitigating neuroinflammation. By addressing both macrovascular and microvascular factors, it may be possible to translate angiographic success into meaningful functional recovery.

PMID:
42566118
Bibliographic data and abstract were imported from PubMed on 07 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement